Clinical Trial Update: Staccato Fentanyl Single and Multidose PK [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of Staccato Fentanyl in breakthrough pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breakthrough Pain

Drugs mentioned

• Staccato Fentanyl (fentanyl)

Snippet

Sponsor: Alexza Pharmaceuticals, Inc. | Conditions: Breakthrough Pain | Phase 1 | Status: COMPLETED